Sanofi-Aventis and Bristol-Myers Squibb announced that they'd nabbed FDA approval for a new 300 mg strength of the anti-clotting drug Plavix, for use as a loading dose when heart patients come into the ER. Release [1]
Sanofi-Aventis and Bristol-Myers Squibb announced that they'd nabbed FDA approval for a new 300 mg strength of the anti-clotting drug Plavix, for use as a loading dose when heart patients come into the ER. Release [1]
Links:
[1] http://www.fiercebiotech.com/press-releases/press-release-fda-approves-sanofi-aventis-and-bristol-myers-squibb-new-300mg-loading-